Elsevier Launches Biofuel Research and Discovery Tool, Accelerating BioEnergy Research and Development
NEW YORK, July 21, 2011 /PRNewswire/ --
New Tool Enables the Successful Commercialisation of Alternative Energy Technologies
Elsevier, the world-leading provider of scientific, technical and medical information products and services, today announced the launch of Elsevier Biofuel, an online search and discovery tool that provides biofuel managers and research development professionals instant access to the highest level of scientific, industrial, and commercial information to solve their continued innovation requirements. Through a wealth of content and information, Elsevier Biofuel will assist companies in making key decisions surrounding the Biofuel and the Bio-energy markets, making developments in the industry quicker and more efficient.
"BioEnergy RD&D (Research, Development and Demonstration) is a complex interdisciplinary challenge," commented Marcus Gay, Biofuels Information Consultant, Elsevier Biofuels. "As a former BioEnergy R&D manager I am acutely aware of the technical, economic and commercial challenges faced by professionals in the industry. Elsevier's Biofuel Information Discovery Tool pulls together scientific and commercial information enabling researchers to have this critical binocular vision during every stage of the development process."
The Elsevier Biofuel tool allows users to drill down to keywords that pinpoint the exact information needed. Moreover, with the Elsevier Biofuel Tree Thesaurus (EBTT), research professionals can easily and accurately navigate through more than 900 journals and 800 books, 5.8 million patent documents, enriched with 500,000 domain specific keywords in the thesaurus and growing. The platform also allows users to compare high-quality data specific to the biofuels industry including:
- solve problems with existing scientific knowledge
- research new, promising advanced technologies
- compare applicable approved pathways and methodologies
- minimise waste in resources
"Having tested the beta version of Elsevier Biofuels discovery tool thoroughly, it became immediately apparent how limiting the information returned from internet only search is, by comparison", said Dr. Skye Thomas-Hall, Senior Scientist, Cellana LLC, (a subsidiary of Cellana, Inc. a Kona-headquartered developer of algae-based biofuels and Bioproducts). "The combination of high quality journal, book and patent information in one location, is a huge advantage that increased my efficiency by at least 15-20%."
About Elsevier Biofuels
Elsevier Biofuels online discovery platform was designed specifically to help Biofuels R&D professionals find solutions to R&D problems faster and support R&D investments decisions. For further product information, please visit http://www.info.elsevier-biofuel.com
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Vice President, Global Corporate Relations, Elsevier